Does CALCIPOTRIENE Cause Mobility decreased? 36 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Mobility decreased have been filed in association with CALCIPOTRIENE (SORILUX). This represents 2.7% of all adverse event reports for CALCIPOTRIENE.
36
Reports of Mobility decreased with CALCIPOTRIENE
2.7%
of all CALCIPOTRIENE reports
0
Deaths
33
Hospitalizations
How Dangerous Is Mobility decreased From CALCIPOTRIENE?
Of the 36 reports, 33 (91.7%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CALCIPOTRIENE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does CALCIPOTRIENE Cause?
Drug ineffective (663)
Psoriasis (342)
Product use in unapproved indication (147)
Therapeutic product effect incomplete (123)
Pruritus (108)
Treatment failure (102)
Skin exfoliation (97)
Arthralgia (81)
Erythema (79)
Rash (75)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CALCIPOTRIENE Alternatives Have Lower Mobility decreased Risk?
CALCIPOTRIENE vs CALCITONIN
CALCIPOTRIENE vs CALCITONIN SALMON
CALCIPOTRIENE vs CALCITRIOL
CALCIPOTRIENE vs CALCITRIOL\CALCIUM\ZINC
CALCIPOTRIENE vs CALCIUM